Improved Survival in Osteosarcoma Patients with Atypical Low Vascularization

Osteosarcoma Microenvironment: Whole-Slide Imaging and Optimized Antigen Detection Overcome Major Limitations in Immunohistochemical Quantification

(2014) Pierre Kunz et al.   PLoS One

Prognostic Factors in Elderly Osteosarcoma Patients: A Multi-institutional Retrospective Study of 86 Cases

(2013) Shintaro Iwata et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical Predictive Value of Serum Angiogenic Factor in Patients with Osteosarcoma

(2013) Zhe Chen et al.   Asian Pacific Journal of Cancer Prevention

Effects of endostar combined multidrug chemotherapy in osteosarcoma

(2013) Meng Xu et al.   BONE

A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma

(2013) Ding Chen et al.   TUMOR BIOLOGY

Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma

(2012) John Lammli et al.   INTERNATIONAL ORTHOPAEDICS

The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review

(2012) Jin-tao Qu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Primary extremity soft tissue sarcomas: outcome improvement over time at a single institution

(2011) A. Gronchi et al.   ANNALS OF ONCOLOGY

The distribution of IGF2 and IMP3 in osteosarcoma and its relationship with angiogenesis

(2011) Peng Chen et al.   JOURNAL OF MOLECULAR HISTOLOGY

Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) P. C. W. Hogendoorn et al.   ANNALS OF ONCOLOGY

Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis

(2010) Barbara Rossi et al.   BMC MUSCULOSKELETAL DISORDERS